Scarica l'app Stockscreener
7.80
16.07%
1.08
Pre-mercato:
7.81
0.010
+0.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.72
Aprire:
$6.9
Volume 24 ore:
154.83K
Relative Volume:
7.45
Capitalizzazione di mercato:
$107.55M
Reddito:
$49.98M
Utile/perdita netta:
$-9.64M
Rapporto P/E:
-10.99
EPS:
-0.71
Flusso di cassa netto:
$-4.86M
1 W Prestazione:
+24.60%
1M Prestazione:
+14.71%
6M Prestazione:
+1.83%
1 anno Prestazione:
+23.22%
Intervallo 1D:
$6.90
$8.3099
Intervallo di 1 settimana:
$6.16
$8.3099
Portata 52W:
$5.592
$11.99
Champions Oncology Inc Stock (CSBR) Company Profile
Nome
Champions Oncology Inc
Settore
Industria
Telefono
410-369-0365
Indirizzo
855 N. WOLFE STREET, BALTIMORE, NJ
Confronta CSBR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
7.80 | 92.66M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-12 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2019-11-18 | Iniziato | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Borsa (CSBR) Ultime notizie
Champions Oncology Inc Stock Analysis and ForecastSwing Trading Watchlist & Rapid Capital Portfolio - earlytimes.in
Champions Oncology Inc (CSBR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Champions Oncology earnings beat by $0.05, revenue topped estimates - Investing.com Canada
Champions Oncology signals expanding radiolabeling and data platform as margin improves to 52% - MSN
Earnings call transcript: Champions Oncology Q2 2025 sees strong revenue growth - Investing.com Canada
Champions Oncology Q2 Non-GAAP Earnings Fall, Revenue Rises - marketscreener.com
CHAMPIONS ONCOLOGY, INC. SEC 10-Q Report - TradingView — Track All Markets
Champions Oncology Reports Record Quarterly Service Revenue - TradingView — Track All Markets
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million - ACCESS Newswire
Champions Oncology (NASDAQ: CSBR) lifts Q2 revenue 11% to $15M, earns profit - Stock Titan
Liquidity Mapping Around (CSBR) Price Events - news.stocktradersdaily.com
First Look: iRobot Bankruptcy, Netflix-WBD Fight, Tesla Robotaxi - GuruFocus
Earnings Scheduled For December 15, 2025 - Benzinga
Dow Settles Lower But Records Weekly Gain: Investor Sentiment Declines, Greed Index Moves To 'Fear' Zone - Benzinga
Argenx, Navan And 3 Stocks To Watch Heading Into Monday - Benzinga
Investors in Champions Oncology (NASDAQ:CSBR) from five years ago are still down 41%, even after 11% gain this past week - simplywall.st
Ocean Power Tech, Champions Oncology set to report earnings Monday By Investing.com - Investing.com Nigeria
Ocean Power Tech, Champions Oncology set to report earnings Monday - Investing.com
Insights Ahead: Champions Oncology's Quarterly Earnings - Benzinga
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025 - ACCESS Newswire
Shareholders in Champions Oncology (NASDAQ:CSBR) are in the red if they invested five years ago - Yahoo Finance
Will Champions Oncology Inc. (2I3) stock beat value stocks2025 Stock Rankings & Expert Curated Trade Setups - Newser
Will Champions Oncology Inc. stock deliver consistent dividendsJuly 2025 Review & AI Enhanced Trade Execution Alerts - Newser
Will Champions Oncology Inc. (2I3) stock outperform benchmarksInflation Watch & Technical Pattern Based Buy Signals - Newser
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH) and Champions Oncology (CSBR) - The Globe and Mail
Why (CSBR) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Why Champions Oncology Inc. (2I3) stock is a strong buy callWeekly Trade Recap & Breakout Confirmation Alerts - Newser
Will Champions Oncology Inc. stock benefit from infrastructure spending2025 Performance Recap & Step-by-Step Swing Trade Plans - Newser
Why pension funds invest in Champions Oncology Inc. (2I3) stock2025 Top Gainers & Verified Short-Term Trading Plans - Newser
Will Champions Oncology Inc. (2I3) stock deliver stable dividendsJuly 2025 Trends & Weekly Return Optimization Alerts - Newser
What drives Champions Oncology Inc 2I3 stock priceMonthly Performance Summary & Achieve Triple Digit Returns - earlytimes.in
Patient-Derived Xenograft Model Market Size at USD 1.12 Billion in 2031, Forecasted to Grow at 13.4% CAGR Through 2031 | The Insight Partners (PR Newswire) - Aktiellt
Understanding Momentum Shifts in (CSBR) - news.stocktradersdaily.com
Will Champions Oncology Inc. stock outperform Nasdaq indexWeekly Stock Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Quantitative breakdown of Champions Oncology Inc. recent move2025 Big Picture & Verified Entry Point Signals - newser.com
What dividend safety rating applies to Champions Oncology Inc. (2I3) stockDip Buying & Free Fast Entry Momentum Trade Alerts - newser.com
How Champions Oncology Inc. (2I3) stock behaves in tightening cycles2025 Pullback Review & Free Weekly Chart Analysis and Trade Guides - newser.com
Candlestick signals on Champions Oncology Inc. stock todayJuly 2025 Levels & Risk Adjusted Swing Trade Ideas - newser.com
Published on: 2025-11-19 21:53:34 - newser.com
How Champions Oncology Inc. (2I3) stock reacts to weak economy - newser.com
Why Champions Oncology Inc. is moving todayPortfolio Growth Summary & Real-Time Buy Signal Alerts - newser.com
Is Champions Oncology Inc. stock a buy in volatile marketsEarnings Recap Summary & Short-Term High Return Strategies - newser.com
Champions Oncology Inc Azioni (CSBR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):